Astera Labs, INC Form 4 insider transactions

Astera Labs, Inc. Director Bethany Mayer was granted 2,351 restricted stock units (RSUs) on June 8, 2025, as part of the company's 2024 Stock Option and Incentive Plan.

Astera Labs' President and COO, Sanjay Gajendra, sold 88,627 shares of common stock for approximately $8.7 million on June 4, 2025, through a pre-established Rule 10b5-1 trading plan.

Astera Labs' Chief Financial Officer, Michael Truett Tate, sold 499,000 shares of common stock on May 30, 2025, through a pre-arranged 10b5-1 trading plan.

Astera Labs Director Manuel Alba sold 600 shares of common stock for $100 per share on May 29, 2025, as part of a pre-established Rule 10b5-1 trading plan.

Astera Labs, Inc. CEO and Director Jitendra Mohan reported the sale of 14,200 shares of common stock for approximately $1.42 million, executed automatically under a Rule 10b5-1 trading plan.

Astera Labs' President and COO, Sanjay Gajendra, sold 165,000 shares of common stock for approximately $16.2 million through a pre-established Rule 10b5-1 trading plan.

Astera Labs CEO Jitendra Mohan sold 106,875 shares of common stock on May 19, 2025, at an average price of $90.0195, pursuant to a pre-arranged Rule 10b5-1 trading plan.

Sanjay Gajendra, President and COO of Astera Labs, sold shares of common stock on May 16, 2025, to cover tax withholding obligations related to vesting restricted stock units.

Astera Labs CEO Jitendra Mohan sold shares of common stock on May 16, 2025, to cover tax withholding obligations related to the vesting of restricted stock units.

Philip Mazzara, General Counsel and Secretary of Astera Labs, sold shares of common stock to cover tax obligations and under a pre-arranged 10b5-1 trading plan.

Astera Labs CFO Michael Truett Tate sold shares of common stock on May 16, 2025, to cover tax withholding obligations related to vesting restricted stock units.

Director Michael Hurlston of Astera Labs, Inc. executed multiple sales of common stock on May 15, 2025, under a pre-arranged Rule 10b5-1 trading plan.

Philip Mazzara, General Counsel and Secretary of Astera Labs, acquired 196 shares of common stock through the company's Employee Stock Purchase Plan.

Astera Labs CEO Jitendra Mohan sold 75,000 shares of common stock at a price of $90.9032 per share on May 14, 2025, under a pre-arranged Rule 10b5-1 trading plan.

Sanjay Gajendra, President and COO of Astera Labs, sold shares of common stock on May 8, 2025, under a pre-arranged Rule 10b5-1 trading plan.

Astera Labs CEO Jitendra Mohan sold 87,500 shares of common stock on May 8, 2025, for approximately $71.05 per share, totaling around $4.26 million, under a pre-arranged Rule 10b5-1 trading plan.

Director Manuel Alba sold shares of Astera Labs (ALAB) on April 2nd and 3rd, 2025, under a pre-arranged Rule 10b5-1 trading plan.

Astera Labs CEO Jitendra Mohan sold 75,000 shares of common stock on March 3, 2025, at a weighted average price of $71.3688, pursuant to a pre-arranged Rule 10b5-1 trading plan.

Director Craig H. Barratt acquired 3,637 shares of Astera Labs, Inc. common stock through a grant of restricted stock units.

Chief Financial Officer Michael Tate of Astera Labs reports gifting shares to trusts and a non-affiliated entity, as well as selling shares on February 26, 2025.

Astera Labs CEO Jitendra Mohan sold shares of common stock on February 19, 2025, to cover tax withholding obligations related to the vesting of restricted stock units.

Sanjay Gajendra, President and COO of Astera Labs, sold shares of common stock on February 19, 2025, to cover tax withholding obligations related to vesting restricted stock units.

Philip Mazzara, General Counsel and Secretary of Astera Labs, Inc. (ALAB), sold shares of common stock on February 18 and 20, 2025, to cover tax obligations and under a pre-arranged Rule 10b5-1 trading plan.

Michael Truett Tate, CFO of Astera Labs, sold shares of common stock to cover tax withholding obligations related to vesting restricted stock units.

Director Michael Hurlston of Astera Labs sold shares of common stock on February 18, 2025, under a pre-arranged Rule 10b5-1 trading plan.

Director Jack R. Lazar of Astera Labs, Inc. sold common stock in multiple transactions on February 18, 2025, under a pre-arranged Rule 10b5-1 trading plan.

Astera Labs' Chief Financial Officer, Michael Tate, gifted a total of 50,000 common shares to a non-affiliated party.

Astera Labs' Chief Financial Officer, Michael Tate, sold a portion of his shares through a pre-arranged 10b5-1 trading plan.

Director Manuel Alba of Astera Labs sold a total of 10,900 shares of common stock on December 4, 2024, through a pre-arranged 10b5-1 trading plan.

Director Manuel Alba of Astera Labs sold a significant number of shares over two days, December 2nd and 3rd, under a pre-arranged 10b5-1 trading plan.